Table 3.
Univariate Analysis of the Study Patients (N = 80): Molecular Variables
| Variable {“Gene?”} | Mutationa | n | OR | 95% CI | P |
|---|---|---|---|---|---|
| APC | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| BRAF | 0 | 78 | — | — | .6671 |
| 1 | 2 | 1.5837893 | 0.19–13.36 | ||
| CDKN2A | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| EGFR | 0 | 67 | — | — | .3197 |
| 1 | 13 | 0.5516976 | 0.16–1.86 | ||
| FBXW7 | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| FGFR3 | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| IDH1 | 0 | 66 | — | — | <.0001 |
| 1 | 14 | 97.8096211 | 10.79–886.91 | ||
| KRAS | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| MUTYH | 0 | 78 | — | — | .6769 |
| 1 | 2 | 0.5930654 | 0.05–7.64 | ||
| NF1 | 0 | 75 | — | — | .3161 |
| 1 | 5 | 0.4264895 | 0.07–2.50 | ||
| PIK3CA | 0 | 73 | — | — | .4826 |
| 1 | 7 | 1.6332647 | 0.41–6.59 | ||
| PTEN | 0 | 69 | — | — | .0235 |
| 1 | 11 | 0.2313771 | 0.06–0.94 | ||
| PTPN11 | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| SUFU | 0 | 79 | — | — | |
| 1 | 1 | — | — | ||
| TP53 | 0 | 57 | — | — | .0622 |
| 1 | 23 | 2.4522865 | 0.93–6.45 |
a0, no mutation; 1, mutation.